Skip to search formSkip to main contentSkip to account menu

IEM 1913

Known as: IEM-1913, IEM1913 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Bridged-Ring CompoundsPutrescine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Comparison of the Chronic Anticonvulsant Activity and Safety of IEM-1913, Sodium Valproate, IEM-1676, and Memantine in Experiments on Rats
Chronic oral administration of the selective AMPA receptor blocker IEM-1676 and the combined NMDA and AMPA receptor blocker IEM… 
2019
2019
Synthesis and Pharmacological Properties of Adamantane-Containing Bis-Cationic Compounds
The bis-cationic compound 1-amino-4-(1-adamantanamino)butane dihydrochloride (IEM-1913) has important advantages over clinically… 
2016
2016
IEM-1913 - New Effective and Safe Glutamate Antagonist Comparedwith Memantine
Adamantan-containing glutamate antagonist IEM-1913, 1-amino-4- (1-adamantanamino)butane dihydrochloride, has antiparkinson… 
2015
2015
Comparison of Pharmacological Potency and Safety of Glutamate Blocker IEM-1913 and Memantine
Adamantane-containing glutamate blocker IEM-1913 (1-amino-4-(1-adamantane-amino)-butane dihydrochloride) equals to memantine in… 
2007
2007
[Combined blockade of GluR1 AMPA and NMDA receptors effectively eliminates neurological disorders in rats with experimental allergic encephalomyelitis].
The experimental allergic encephalomyelitis (EAE) developed on the 11 - 12th day after inoculation of encephalitogenic mixture in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)